Syros Pharmaceuticals, Inc.
SYRS · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6 | -$23 | -$4 | -$64 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $8 |
| Stock-Based Comp. | $2 | $2 | $2 | $2 |
| Change in WC | $4 | -$4 | -$3 | $6 |
| Other Non-Cash | -$20 | -$5 | -$27 | $29 |
| Operating Cash Flow | -$21 | -$30 | -$31 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | -$0 |
| Net Acquisitions | -$0 | $0 | $0 | $2 |
| Inv. Purchases | $0 | $0 | -$25 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $25 | $0 | $0 |
| Investing Cash Flow | $0 | $25 | -$25 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | -$0 | $0 | $0 | $43 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $0 |
| Financing Cash Flow | $0 | $0 | -$0 | $43 |
| Forex Effect | $0 | $0 | $0 | $1 |
| Net Chg. in Cash | -$21 | -$5 | -$56 | $27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81 | $84 | $140 | $112 |
| End Cash | $60 | $79 | $84 | $140 |
| Free Cash Flow | -$21 | -$30 | -$31 | -$19 |